AIMC Topic: Coronary Restenosis

Clear Filters Showing 11 to 11 of 11 articles

Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions.

Terapevticheskii arkhiv Sep 20, 2018
AIM: The urgency of the study is determined by the lack of data necessary in order to assess the safety of prolonged use of proton pump inhibitors (PPI) in patients with IHD combined with anti-aggregant therapy. The aim of the study was to study the ...
Humans Prospective Studies Prognosis Female Aged Male Middle Aged Registries Percutaneous Coronary Intervention Coronary Restenosis Acute Coronary Syndrome Drug Therapy, Combination Gastrointestinal Hemorrhage Russia Long Term Adverse Effects Myocardial Ischemia Platelet Aggregation Inhibitors Proton Pump Inhibitors Risk Adjustment
View on PubMed DOI
Popular Topics
Recent Journals